# 12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)

> **NIH NIH R13** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2021 · $11,000

## Abstract

SUMMARY
The International Conference on the Molecular Biology and Pathogenesis of the Clostridia (Clostpath) has been
the leading venue to bring together scientists, clinicians, and pathologists at the forefront of research on the
molecular biology of clostridia and their role in health and disease. In keeping with this tradition, Clostpath12 will
cover all fundamental and translational aspects of clostridial-dependent pathogenesis. Topics will include
virulence gene regulation, virulence factor structure and mechanism, host-pathogen-microbiome interactions,
spore dynamics and transmission, the development of new technologies to study clostridial organisms, as well
as innovations designed for the detection, diagnosis, treatment and prevention of clostridial-caused diseases.
The meeting will take place September 13-16, 2021 in Banff, Alberta, which is located in the heart of the
Canadian Rockies.
The programming for Clostpath12 is deliberate in its focus on diversity and inclusion as well as providing
opportunities to young scientists. At Clostpath conferences, there are traditionally 9 sessions, with 12-20 invited
speakers – all plenary (no parallel sessions). Approximately 25 additional oral presentations will be selected from
submitted abstracts. The Organizing Committee, the International Steering Committee, and the list of invited
speakers reflect the full geographic, scientific, and ethnic/gender/racial diversity of the Clostpath community.
There will be ~150 posters presented, divided over two poster sessions. During the plenary presentations, there
will also be flash talks for selected poster abstracts. To foster networking interactions, there is a social program
that includes a welcome reception/working dinner on the first day of the conference, a conference dinner/party
on the final evening, and optional excursions. In addition, a young scientist committee is developing trainee-
specific content and activities to be integrated into the program.
The objectives for the 12th Conference will be (i) to continue presenting the highest-quality, recent research on
pathogenic clostridia in a forum that facilitates information exchange and future collaborations and (ii) to train
and inspire young clostridial researchers who will be the next generation of leaders in the field. These objectives
will be realized through two specific aims: Aim 1: Invite, support, and encourage the participation of young
investigators and underrepresented scientists. Aim 2: Provide a setting that encourages collegial exchange of
scientific ideas and sharing of the most current discoveries in the field.

## Key facts

- **NIH application ID:** 10318438
- **Project number:** 1R13AI164791-01
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Dana Borden Lacy
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $11,000
- **Award type:** 1
- **Project period:** 2021-07-12 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10318438

## Citation

> US National Institutes of Health, RePORTER application 10318438, 12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12) (1R13AI164791-01). Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/grant/nih/10318438. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*